Forian Inc.FORAEarnings & Financial Report
Forian Inc is a specialized healthcare technology and data analytics firm offering SaaS-based real-world evidence solutions, clinical decision support tools, and operational optimization services. It serves biopharmaceutical companies, healthcare providers, and life sciences stakeholders to improve patient outcomes, accelerate research, and boost care delivery efficiency.
Revenue
$5.8M
Gross Profit
$3.4M
Operating Profit
$-1.4M
Net Profit
$199.7K
Gross Margin
58.3%
Operating Margin
-24.9%
Net Margin
3.4%
YoY Growth
5.5%
EPS
$0.01
Forian Inc. Q4 FY2024 Financial Summary
Forian Inc. reported revenue of $5.8M (up 5.5% YoY) for Q4 FY2024, with a net profit of $199.7K (down 86.8% YoY) (3.4% margin). Cost of goods sold was $2.4M, operating expenses totaled $4.8M.
Key Financial Metrics
| Total Revenue | $5.8M |
|---|---|
| Net Profit | $199.7K |
| Gross Margin | 58.3% |
| Operating Margin | -24.9% |
| Report Period | Q4 FY2024 |
Revenue Breakdown
Forian Inc. Q4 FY2024 revenue of $5.8M breaks down across 3 segments, led by November2020Agreement at $3.4M (58.5% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| November2020Agreement | $3.4M | 58.5% |
| Deferred Revenue | $2.0M | 34.0% |
| Other | $435.0K | 7.5% |
Forian Inc. Revenue by Segment — Quarterly Trend
Forian Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as November2020Agreement and Deferred Revenue) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Other | $669.0K | $261.5K | — | — |
Forian Inc. Annual Revenue by Year
Forian Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $30.3M).
| Year | Annual Revenue |
|---|---|
| 2025 | $30.3M |
| 2024 | $20.2M |
| 2023 | $21.2M |
| 2022 | $16.4M |
Forian Inc. Quarterly Revenue & Net Profit History
Forian Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $8.0M | +37.0% | $-1.8M | -22.9% |
| Q3 FY2025 | $7.8M | +65.6% | $-151.2K | -1.9% |
| Q2 FY2025 | $7.5M | +56.5% | $224.8K | 3.0% |
| Q1 FY2025 | $7.1M | +44.7% | $-1.1M | -16.0% |
| Q4 FY2024 | $5.8M | +5.5% | $199.7K | 3.4% |
| Q3 FY2024 | $4.7M | -15.3% | $-204.9K | -4.4% |
| Q2 FY2024 | $4.8M | -6.3% | $-2.6M | -53.4% |
| Q1 FY2024 | $4.9M | -3.9% | $-1.2M | -24.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9M | $4.8M | $4.7M | $5.8M | $7.1M | $7.5M | $7.8M | $8.0M |
| YoY Growth | -3.9% | -6.3% | -15.3% | 5.5% | 44.7% | 56.5% | 65.6% | 37.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $57.5M | $58.4M | $57.5M | $47.2M | $48.6M | $48.5M | $41.3M | $44.1M |
| Liabilities | $31.0M | $32.7M | $30.6M | $17.1M | $18.6M | $17.5M | $10.2M | $14.4M |
| Equity | $28.1M | $27.2M | $28.4M | $30.1M | $30.0M | $30.9M | $31.1M | $29.8M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.2M | $-23110 | $764096 | $1.7M | $448180 | $-344531 | $-439666 | $3.2M |